Second, the current data and analysis of public transcriptome data sets showed increased SREBF-1 mRNA expression in localized PCa, which was even more pronounced in metastatic PCa than in benign tissue, implicating an increasing relevance of SREBPs in the process of therapy resistance. Here, SREBF1 is linked to posterior cortical atrophy.